CDX2 and colorectal carcinoma: Although we can in principal confirm the results from previous studies such as the one from Dalerba et al. [17] that CDX2 is of some prognostic importance in univariate analyses in specific stage groups of CRC, our data for Stage II/III CRCs are comparable to the overall cohort, meaning that the purely morphological parameters allow for a significantly better assessment of different prognostic groups.